Sichtbarkeits-Score
100/100
KI-Erwähnungen
7.3K
KI-Suchvolumen
4.3M
Mit Stand vom 17. Februar 2026 erzielt Eli Lilly (lilly.com) einen KI-Sichtbarkeits-Score von 100 von 100, basierend auf insgesamt 7.3K KI-Erwähnungen über Plattformen wie Google KI-Übersichten und ChatGPT hinweg. Die Marke generiert ein KI-Suchvolumen von 4.3M. Im Bereich des traditionellen SEO verzeichnet Eli Lilly geschätzte 3.0M monatliche organische Besuche mit einem Traffic-Wert von $29.9M. Im Vergleich zu Mitbewerbern aus dem Life-Sciences-Sektor belegt Eli Lilly beim Share of Voice der KI-Erwähnungen Rang #2 von 5.
Eli Lilly and Company is a major American pharmaceutical company known for its diabetes treatments (including Mounjaro and Zepbound GLP-1 receptor agonists), oncology drugs, immunology therapies, and neuroscience pipeline. It is one of the fastest-growing pharma companies by market capitalization.
Aufschlüsselung der KI-Sichtbarkeit
Eli Lilly verzeichnet insgesamt 7.3K KI-Erwähnungen über 2 erfasste Plattformen hinweg und generiert ein KI-Suchvolumen von 4.3M. Auf Google AI Overview entfällt mit 86 % aller Erwähnungen der größte Anteil. KI-Plattformen verknüpfen Eli Lilly mit 20 Marken-Entitäten, darunter Zepbound, Mounjaro, Eli Lilly and Company.
Nach Plattform
Marken-Entitäten
Am häufigsten zitierte Seiten
KI-Antworten mit Erwähnung von Eli Lilly
Beispielhafte Fragen, bei denen KI-Plattformen Eli Lilly in ihren Antworten zitieren.
zepbound
Marke zitiert5 Quellen
zepbound
Zepbound (tirzepatide) is an FDA-approved prescription injectable medication for chronic weight management in adults with obesity or overweight with weight-related conditions, and also for adults with moderate-to-severe obstructive sleep apnea (OSA) . It works by mimicking natural hormones (GLP-1 and GIP) to reduce appetite, increase fullness, and slow stomach emptying, leading to less food intake and significant weight loss, alongside diet and exercise. Administered weekly, Zepbound has shown substantial weight reduction and improved OSA symptoms in clinical trials, but common side effects include nausea, diarrhea, and constipation, with rare serious risks like pancreatitis.12345
How it works
cymbalta
Marke zitiert5 Quellen
cymbalta
Cymbalta (generic name: duloxetine ) is a prescription medication classified as a serotonin-norepinephrine reuptake inhibitor (SNRI) . It is primarily used to treat mental health conditions like depression and anxiety, as well as chronic pain disorders.1234
Uses
Cymbalta is FDA-approved to treat the following conditions in adults:12
- Major Depressive Disorder (MDD)
- Generalized Anxiety Disorder (GAD) (also approved for children 7+ years old)
- Fibromyalgia (also approved for children 13+ years old)
- Diabetic Peripheral Neuropathic Pain (nerve pain)
- Chronic Musculoskeletal Pain (e.g., lower back pain or osteoarthritis)1234
How It Works
Cymbalta works by increasing the levels of serotonin and norepinephrine in the brain and spinal cord. These neurotransmitters are responsible for regulating mood and decreasing pain signals.123
Side Effects
Common side effects of Cymbalta include:123
- Nausea
- Dry mouth
- Constipation
- Fatigue
- Drowsiness
- Increased sweating
- Loss of appetite
- Sexual dysfunction12345
Serious Warnings:
- Suicidal Thoughts: Like other antidepressants, Cymbalta can increase the risk of suicidal thoughts and behaviors in children, adolescents, and young adults.
- Withdrawal Symptoms: Stopping Cymbalta abruptly can cause withdrawal symptoms (dizziness, nausea, headache, irritability, burning/prickling sensations).
- Liver Damage: High doses or use with alcohol can cause liver damage.
- Serotonin Syndrome: A rare but serious condition that can occur, especially when combined with other drugs.12345
Dosage
- Common Dosage: The standard dose for many conditions is 60 mg daily, usually taken in 30 mg or 60 mg capsules, once or twice a day.
- Administration: Capsules should be swallowed whole; they should not be crushed or chewed.
- Tapering: When stopping the medication, a doctor will generally recommend a gradual reduction in dosage to avoid withdrawal.1234
Important Considerations
- Drug Interactions: Do not take Cymbalta with Monoamine Oxidase Inhibitors (MAOIs), as this can cause a fatal reaction.
- Pregnancy/Breastfeeding: Use during the later part of pregnancy may increase the risk of postpartum hemorrhage and neonatal complications.
- Effectiveness: While highly effective, it does not cure these conditions and usually works to reduce symptoms over time, often taking 4–8 weeks for full effect.123456
Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional for diagnosis and treatment.
mounjaro side effects
Marke zitiert5 Quellen
mounjaro side effects
The most common side effects of Mounjaro are gastrointestinal, including nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, and stomach pain . Many of these digestive issues are mild to moderate and may diminish after a few weeks as the body adjusts to the medication. Less common but more serious side effects are also possible.
Common side effects
- Gastrointestinal issues: Nausea, diarrhea, vomiting, constipation, indigestion, abdominal pain, and decreased appetite are the most frequently reported side effects.
- Injection site reactions: Some people may experience redness, itching, or pain where the injection was given.
- Hypoglycemia (low blood sugar): This is a greater risk if you take Mounjaro with other diabetes medications like insulin or sulfonylureas. Symptoms include dizziness, shakiness, sweating, anxiety, irritability, and a fast heartbeat.
- Fatigue.
- Hair loss.
eli lilly company
Marke zitiert5 Quellen
eli lilly company
Eli Lilly and Company is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, that discovers, develops, and markets human pharmaceuticals.The company was founded in 1876 by Colonel Eli Lilly and focuses on therapeutic areas like oncology, diabetes, neuroscience, and immunology.Its products include well-known drugs like Trulicity, Mounjaro, and Verzenio.
Company overview
- Headquarters: Indianapolis, Indiana
- Founded: 1876 by Colonel Eli Lilly
- Global presence: Products are sold in approximately 125 countries
- Mission: To put health above all and create medicines that make life better for people around the world12345
Therapeutic areas
- Cardiometabolic health: Focuses on diabetes and other cardiometabolic conditions
- Oncology: Includes cancer treatments
- Immunology: Addresses autoimmune diseases
- Neuroscience: Focuses on neurological and psychiatric disorders1234
Key products
trulicity
Marke zitiert5 Quellen
trulicity
Trulicity (dulaglutide) is a once-weekly injectable medication for adults and children (10+) with type 2 diabetes , used with diet and exercise to control blood sugar and reduce major heart problems (heart attack, stroke) in at-risk individuals, working by mimicking the GLP-1 hormone to boost insulin, slow digestion, and decrease appetite.Common side effects include nausea, diarrhea, vomiting, abdominal pain, and appetite decrease, but it carries a boxed warning for potential thyroid C-cell tumors (like MTC) and is contraindicated with a personal/family history of MTC or MEN 2. Patients inject it themselves under the skin, using a prefilled pen, and should monitor for serious signs like severe stomach pain, trouble swallowing, or signs of dehydration.
Uses
- Type 2 Diabetes: Improves glycemic control alongside diet and exercise in adults and children 10+.12
- Cardiovascular Risk Reduction: Lowers risk of heart attack, stroke, and cardiovascular death in adults with type 2 diabetes and established heart disease or risk factors.123
How it Works (Mechanism)
- It's a GLP-1 receptor agonist that mimics the natural hormone glucagon-like peptide-1 (GLP-1).
- Stimulates insulin release when blood sugar is high.
- Reduces glucose production in the liver.
- Slows stomach emptying, which helps control post-meal blood sugar spikes.
- Decreases appetite, potentially leading to weight loss.123
Administration
- A once-weekly, subcutaneous (under the skin) injection.
- Administered using a prefilled pen with firm pressure on the skin.1234
Side Effects & Warnings (Black Box Warning)
- Common: Nausea, diarrhea, vomiting, abdominal pain, decreased appetite.12
- Serious Risks (requires immediate medical attention):
- Thyroid Tumors: Risk of thyroid C-cell tumors, including Medullary Thyroid Carcinoma (MTC).1
- Pancreatitis: Severe stomach pain, nausea, vomiting.12
- Allergic Reactions: Rash, swelling, trouble breathing.1
- Kidney Problems: Decreased urination, swelling.1
- Vision Changes.1
- Suicidal Thoughts/Depression.12
- Contraindications: Do not use if you have a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).1
SEO-Performance
Eli Lilly rankt für 176.5K organische Keywords und erzielt geschätzte 3.0M monatliche Besuche mit einem Traffic-Wert von $29.9M. Der organische Traffic ist im erfassten Zeitraum von 5.3M auf 6.8M gewachsen. Zu den am höchsten rankenden Keywords gehören „pharmacy near me“ (Position 81), „pharmacy“ (Position 66), „tirzepatide“ (Position 1).
Organischer Traffic
3.0M
geschätzte monatliche Besuche
Organische Keywords
176.5K
rankende Keywords
Traffic-Wert
$29.9M
geschätzter monatlicher Wert
Traffic-Trend
Top-Suchbegriffe
| Suchbegriff | Platzierung | Suchvolumen |
|---|---|---|
| pharmacy near me | 81 | 2.2M |
| pharmacy | 66 | 1.5M |
| tirzepatide | 1 | 1.0M |
| tirzepatide | 2 | 1.0M |
| manjaro | 30 | 823.0K |
| mounjaro | 1 | 823.0K |
| zepbound | 1 | 823.0K |
| company's | 39 | 550.0K |
| dubai states | 74 | 550.0K |
| script express | 93 | 550.0K |
| covermymeds | 56 | 450.0K |
| duloxetine | 61 | 450.0K |
| duloxetine drugs | 75 | 450.0K |
| fluoxetine | 67 | 450.0K |
| s/a | 77 | 450.0K |
| jardiance | 8 | 368.0K |
| moore julianne | 65 | 368.0K |
| advi careers | 59 | 301.0K |
| brand mark usa | 77 | 301.0K |
| caremark cvs | 89 | 301.0K |
Share of Voice im Vergleich zu Mitbewerbern
Eli Lilly belegt Platz #2 von 5 Mitbewerbern beim Share of Voice für AI-Erwähnungen und erzielt 18 % aller Erwähnungen. Pfizer führt mit 24.2K AI-Erwähnungen. Zu den erfassten Mitbewerbern gehören Pfizer, Merck & Co., AbbVie, Novo Nordisk.
AI-Erwähnungen
Vergleich
| Unternehmen | Erwähnungen | AI-Volumen |
|---|---|---|
| lilly.com (Sie) | 6.2K | 4.3M |
| novonordisk.com (Novo Nordisk) | 475 | 268.5K |
| pfizer.com (Pfizer) | 24.2K | 18.7M |
| merck.com (Merck & Co.) | 2.3K | 1.4M |
| abbvie.com (AbbVie) | 1.4K | 533.0K |
Verbessern Sie für Ihre Marke die KI-Sichtbarkeit
Dies ist eine statische Momentaufnahme. Das fortlaufende KI-Sichtbarkeits-Monitoring, das Mitbewerber-Benchmarking und die quellengestützten GEO-Inhalte, die Ihren Zitationsfußabdruck verbessern, sind im schlüsselfertigen Wachstumsmotor von VayoMed enthalten.
